119 related articles for article (PubMed ID: 37935109)
1. Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.
Chen CS; Zirpoli G; Barlow WE; Budd GT; McKiver B; Pusztai L; Hortobagyi GN; Albain KS; Damaj MI; Godwin AK; Thompson A; Henry NL; Ambrosone CB; Stringer KA; Hertz DL
J Natl Compr Canc Netw; 2023 Nov; 21(11):1172-1180.e3. PubMed ID: 37935109
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.
Jennaro TS; Fang F; Kidwell KM; Smith EML; Vangipuram K; Burness ML; Griggs JJ; Van Poznak C; Hayes DF; Henry NL; Hertz DL
Breast Cancer Res Treat; 2020 Apr; 180(3):707-714. PubMed ID: 32166478
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221.
Chen CS; Zirpoli G; Thomas Budd G; Barlow WE; Pusztai L; Hortobagyi GN; Albain KS; Godwin AK; Thompson A; Lynn Henry N; Ambrosone CB; Stringer KA; Hertz DL
Res Sq; 2023 Sep; ():. PubMed ID: 37693586
[TBL] [Abstract][Full Text] [Related]
5. Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.
Zirpoli GR; McCann SE; Sucheston-Campbell LE; Hershman DL; Ciupak G; Davis W; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Budd GT; Albain KS; Ambrosone CB
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29546345
[TBL] [Abstract][Full Text] [Related]
6. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
[TBL] [Abstract][Full Text] [Related]
7. Patient Characteristics Associated With Chemotherapy-Induced Peripheral Neuropathy Severity in a Phase II Clinical Trial: A Retrospective Analysis.
Zhi WI; Dreyfus N; Lessing A; Galantino M; Piulson L; Kot KL; Li S; Bao T
Oncologist; 2023 Jul; 28(7):604-608. PubMed ID: 36972359
[TBL] [Abstract][Full Text] [Related]
8. Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer.
Mo H; Yan X; Zhao F; Teng Y; Sun X; Lv Z; Cao M; Zhao J; Song G; Pan B; Li H; Zhai J; Xu B; Ma F
JAMA Netw Open; 2022 Nov; 5(11):e2239788. PubMed ID: 36322088
[TBL] [Abstract][Full Text] [Related]
9. Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.
Chen CS; Zirpoli G; Budd GT; Barlow WE; Pusztai L; Hortobagyi GN; Albain KS; Godwin AK; Thompson A; Henry NL; Ambrosone CB; Stringer KA; Hertz DL
Cancer Chemother Pharmacol; 2024 May; ():. PubMed ID: 38814343
[TBL] [Abstract][Full Text] [Related]
10. Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel.
Chen CS; Smith EML; Stringer KA; Henry NL; Hertz DL
Breast Cancer Res Treat; 2022 Aug; 194(3):551-560. PubMed ID: 35760975
[TBL] [Abstract][Full Text] [Related]
11. Persistent weekly paclitaxel-induced peripheral neuropathy in early breast cancer patients enrolled in a randomized trial of cryotherapy.
Shigematsu H; Kimura Y; Itagaki T; Yasui D
Medicine (Baltimore); 2023 Apr; 102(16):e33580. PubMed ID: 37083796
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Nyrop KA; Deal AM; Reeder-Hayes KE; Shachar SS; Reeve BB; Basch E; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Cancer; 2019 Sep; 125(17):2945-2954. PubMed ID: 31090930
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel.
Reyes-Gibby CC; Morrow PK; Buzdar A; Shete S
J Pain; 2009 Nov; 10(11):1146-50. PubMed ID: 19595634
[TBL] [Abstract][Full Text] [Related]
14. Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.
Greenwald MK; Ruterbusch JJ; Beebe-Dimmer JL; Simon MS; Albrecht TL; Schwartz AG
Cancer; 2019 Jan; 125(2):269-277. PubMed ID: 30387871
[TBL] [Abstract][Full Text] [Related]
15. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).
Mongiovi JM; Zirpoli GR; Cannioto R; Sucheston-Campbell LE; Hershman DL; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Thomas Budd G; Albain KS; Ambrosone CB; McCann SE
Breast Cancer Res; 2018 Nov; 20(1):146. PubMed ID: 30486865
[TBL] [Abstract][Full Text] [Related]
16. Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study).
Kuroi K; Shimozuma K; Ohashi Y; Hisamatsu K; Masuda N; Takeuchi A; Aranishi T; Morita S; Ohsumi S; Hausheer FH
Support Care Cancer; 2009 Aug; 17(8):1071-80. PubMed ID: 19089463
[TBL] [Abstract][Full Text] [Related]
17. Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).
Mehrotra S; Sharma MR; Gray E; Wu K; Barry WT; Hudis C; Winer EP; Lyss AP; Toppmeyer DL; Moreno-Aspitia A; Lad TE; Valasco M; Overmoyer B; Rugo H; Ratain MJ; Gobburu JV
AAPS J; 2017 Sep; 19(5):1411-1423. PubMed ID: 28620884
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
Jin L; Zhang Y; Yang W
Int J Gynaecol Obstet; 2020 Jun; 149(3):303-308. PubMed ID: 32133643
[TBL] [Abstract][Full Text] [Related]
19. Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer.
Speck RM; Sammel MD; Farrar JT; Hennessy S; Mao JJ; Stineman MG; DeMichele A
J Oncol Pract; 2013 Sep; 9(5):e234-40. PubMed ID: 23943894
[TBL] [Abstract][Full Text] [Related]
20. Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study.
Salgado TM; Quinn CS; Krumbach EK; Wenceslao I; Gonzalez M; Reed HL; Syverson JG; Etz RS; Vangipuram K; Barker MR; Henry NL; Farris KB; Hertz DL
Support Care Cancer; 2020 Sep; 28(9):4163-4172. PubMed ID: 31897779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
